These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 24408071

  • 1. Denervation of nerve terminals in renal arteries: one-year follow-up of interventional treatment of arterial hypertension.
    Bartuś K, Sadowski J, Kapelak B, Litwinowicz R, Zajdel W, Godlewski J, Bartuś M, Zmudka K, Chrapusta A, Konstanty-Kalandyk J, Węgrzyn P, Sobotka PA.
    Kardiol Pol; 2014; 72(5):425-31. PubMed ID: 24408071
    [Abstract] [Full Text] [Related]

  • 2. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland.
    Bartuś K, Sadowski J, Kapelak B, Zajdel W, Godlewski J, Bartuś S, Bochenek M, Bartuś M, Żmudka K, Sobotka PA.
    Kardiol Pol; 2013; 71(2):152-8. PubMed ID: 23575708
    [Abstract] [Full Text] [Related]

  • 3. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 4. Renal artery sympathetic nerve radiofrequency denervation.
    Bartuś K, Sadowski J, Kapelak B, Litwinowicz R, Podolec J, Bartuś M, Dziewierz A, Bartuś S, Zajdel W, Lakkireddy D.
    Kardiol Pol; 2017 Jan; 75(9):899-906. PubMed ID: 28541590
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL, SYMPLICITY HTN-3 Steering Committee Investigators.
    Lancet; 2022 Oct 22; 400(10361):1405-1416. PubMed ID: 36130612
    [Abstract] [Full Text] [Related]

  • 6. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 7. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program.
    Can J Cardiol; 2014 Jan 10; 30(1):16-21. PubMed ID: 24269056
    [Abstract] [Full Text] [Related]

  • 8. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, ICV-GVM la Roseraie.
    Ann Cardiol Angeiol (Paris); 2013 Dec 10; 62(6):384-91. PubMed ID: 24182849
    [Abstract] [Full Text] [Related]

  • 9. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2015 Apr 07; 65(13):1314-1321. PubMed ID: 25835443
    [Abstract] [Full Text] [Related]

  • 10. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.
    Hypertension; 2014 Sep 07; 64(3):565-72. PubMed ID: 24935940
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renal sympathetic denervation using an externally irrigated radiofrequency ablation catheter for treatment of resistant hypertension - Acute safety and short term efficacy.
    Yalagudri S, Raju N, Das B, Daware A, Maiya S, Jothiraj K, Ravikishore AG.
    Indian Heart J; 2015 Nov 12; 67(3):207-13. PubMed ID: 26138176
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.